Is clozapine still available? Navigating new access and monitoring guidelines
•
4 min read
In a landmark decision in June 2025, the U.S. Food and Drug Administration (FDA) officially eliminated the Clozapine Risk Evaluation and Mitigation Strategy (REMS) program, which had long governed its distribution. This major regulatory update directly answers the question, **is clozapine still available?**, by confirming its continued availability with substantially improved access for patients and clinicians.
